HBOT for late radiation tissue injury: who benefits and when
Official title: Soft Tissue Radiation Injury; Patient Reported Evaluation in a Single Centre Cohort Study (STRIPE)
Run by Karolinska University Hospital · NCT07611864 · Data updated 2026-11-12
This study follows adults with late radiation injury of the bladder or bowel who were treated with hyperbaric oxygen therapy to see who benefits most and when to start treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Karolinska University Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | May 5, 2026 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2040 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT07611864 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 years with late radiation tissue injury who have been treated with hyperbaric oxygen therapy at Karolinska University Hospital.
✕Probably not a fit
Patients with late radiation injury who do not respond to HBOT or who have contraindications to HBOT may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study documents patients with late radiation tissue injury after radiotherapy who received hyperbaric oxygen therapy at Karolinska University Hospital. It aims to describe treatment patterns, timing, and patient characteristics, and to explore associations with outcomes and quality of life. The study will analyze data over time to identify factors linked to better symptom relief and functional improvement. It does not assign treatments but observes real-world use of HBOT in this setting. Findings could inform which patients derive the most benefit and optimal timing for HBOT initiation.
Why it matters
Potential benefit: If successful, the study could help clinicians tailor HBOT use to patients most likely to benefit and improve HRQoL for those with radiation-induced bladder and bowel symptoms.
How similar studies have gone: Previous randomized studies have shown HBOT can improve symptoms and quality of life in radiation-induced tissue injury, supporting the relevance of this observational cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (\>18 years old) * Late radiation tissue injury * Treated with HBOT Exclusion Criteria: * Requested not to be included in the study (Retrospective cohort) * Not signed informed consent (Prospective cohort)
Where it's running
-
Karolinska University Hospital
Stockholm, Sweden Recruiting
Study contacts
- Principal investigator: Anders Kjellberg, MD, PhD — Karolinska University Hospital
- Study coordinator: Anders Kjellberg, MD, PhD
- Email: anders.kjellberg@regionstockholm.se
- Phone: +46760657355
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How types of radiation-caused rectal injury relate to recovery and outcomes
This project will try to see if different clinical types of radiation-caused rectal injury predict recovery and long-term outcomes in adults aged 18–80.
-
Gut microbiome in gynecologic cancer patients with pelvic toxicity
This study looks at whether gut bacteria profiles relate to pelvic toxicity after cancer treatment and how rectal ozone therapy might affect the gut microbiome and symptoms in women with gynecologic tumors.
-
Using dietary supplements to treat rectal injury from radiation
This study is testing whether a dietary supplement called tributyrin can help people with chronic rectal injury from radiation feel better and improve their quality of life.
-
Registry of Chronic Wounds and Ulcers
This study collects information from patients with chronic wounds and ulcers to see how well different treatments are working and to improve the quality of wound care.
-
Using fecal microbiota transplantation to treat radiation-induced proctopathy
This study is testing if fecal microbiota transplantation can help people with severe rectal bleeding caused by radiation treatment feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.